Idris Tolgay Ocal
WinnMed(US)Mayo Clinic Hospital(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Thyroid Cancer Diagnosis and Treatment, HER2/EGFR in Cancer Research, BRCA gene mutations in cancer
Most-Cited Works
- → A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas(2005)433 cited
- → Malignant Peripheral Nerve Sheath Tumors (MPNST): The Mayo Clinic Experience(2011)400 cited
- Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.(2003)
- → Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer(2020)213 cited
- → Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas(2015)135 cited
- → Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer(2021)104 cited
- → Tissue microarray‐based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors(2003)101 cited
- → Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992–1999)(2007)95 cited
- → Use of Preoperative Magnetic Resonance Imaging for Invasive Lobular Cancer: Good, Better, but Maybe not the Best?(2010)78 cited